Interpace Diagnostics Corporation
UEI: F3JTMG615829
• CAGE: 5C4D8
Overview
Parent Awardee
Company Description
Interpace Diagnostics Group provides clinically useful molecular and related first line diagnostic tests for evaluating risk of cancer.
Name
Interpace Diagnostics Corporation
Headquarters
Pittsburgh, PA
United States
United States
Most Recent Award
May 28, 2026
Calculating
Federal contract recipient
INTERPACE DIAGNOSTICS CORPORATION
(UEI F3JTMG615829, CAGE 5C4D8)
is headquartered in Pittsburgh PA.
Its primary registered NAICS is 621511 Medical Laboratories.
The corporation
was founded in April 2004 and
federally registered in
February 2009.
Federal Award Analysis
Interpace Diagnostics Corporation federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
INTERPACE DIAGNOSTICS CORPORATION
UEI
F3JTMG615829
CAGE Code
5C4D8
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 15, 2004
Initial Registration
Feb. 27, 2009
Last Registration
April 15, 2026
Registration Activation
April 15, 2026
Registration Expiration
April 15, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes